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The purpose of the current research was to examine the prevalence of middle ear disease, 
specifically chronic otitis media (OM) in racial/ethnic non-minority (NM) and racial/ethnic 
minority (REM) children. Previous studies (Fleming-Dutra et al., 2014; Smith & Boss, 2010) 
have reported Black and Hispanic children were less likely to be diagnosed with OM. In addition, 
the likelihood of NM and REM children with non-syndromic cleft lip (CL), cleft palate (CP), 
cleft lip and palate (CLP), being diagnosed with chronic OM and then receiving pressure 
equalization (PE) tube treatment was investigated. Finally, the use of PE tube treatment in NM 
and REM children with CL/P based on the expected payer source was explored. 
 The analysis was limited to children birth to five-years, 11-months of age who received 
medical care in NC as reported to the Healthcare Cost and Utilization Project (HCUP) program 
during 2016. A total of 319,682 patient files were accessed for the study. Patients with a primary 
diagnosis of CL/P were identified using ICD-10-CM codes.  
REM children were under-identified in the diagnosis of chronic OM. The findings of this 
study were consistent with previous studies by Fleming-Dutra et al., (2014) and Smith and Boss 
(2010) in which REM children were less likely to be diagnosed with OM compared with NM 
children. Though not significant, REM children were less likely to be born with CP and CLP. 
These results are consistent with Canfield et al., (2006) and Williams et al., (2003) who reported 
rates of oral clefts were higher in NM infants. This study did not identify significant differences 
in the prevalence of chronic OM, PE tube treatment, or the expected payer source for PE tube 
treatment for NM and REM children with CL/P. Future studies should continue to investigate 
what causes delays in seeking or complying with recommendations and how caregivers 
communicate the frequency and severity of OM symptoms.
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CHAPTER I 
 
STATEMENT OF THE PROBLEM 
 
Annually, healthcare providers in the United States (US) treat more than 7.8 million 
children under the age of six-years for a primary Otitis Media (OM) visit (Marom et al. 2014). In 
preschool-aged children, OM has been reported as the most common diagnosis for medical visits, 
with 50% of all children in the US diagnosed with OM before their first birthday and 90% 
diagnosed with OM by their fifth birthday (Smith & Boss, 2010; Teele, Klein &, Rosner, 1989). 
It has been estimated that 40% of children will have six or more recurrences of OM by seven-
years of age (Casselbrant & Mandel, 2003; Vergison et al., 2010). Otitis Media with Effusion 
(OME) and acute otitis media (AOM) are among the most commonly occurring childhood 
illnesses, with OME occurring more frequently than AOM (Chonmaitree, 2000; Rosenfeld et al., 
2013). More recently, Kawai and colleagues (2018) have reported a reduction of six million 
ambulatory visits for OM in children, as a result of the impact of pneumococcal conjugate 
vaccines. This decline was not dependent upon gender, racial/ethnic identification, health 
insurance status (expected payer source), or geographic region. 
Research has shown that racial/ethnic differences exist in the diagnosis of OM. At six-
months of age, Black and Asian infants are less likely to be diagnosed with OM, compared to 
White infants (Vernacchio et al., 2004). Similarly, Smith and Boss (2010) noted fewer Black and 
Hispanic children ranging from less than two-months to 18 years of age, were diagnosed with 
OM, compared to White children. More recently, research conducted by Fleming-Dutra et al., 
(2014) reported the percentage of diagnosis of OM for Black children 14-years of age and 
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younger was significantly lower than non-Black children (White, Asian, American 
Indian/Eskimo/Alaskan, Native Hawaiian/Pacific Islander, other). In short, disparities exist in the 
diagnosis of OM based on racial/ethnic identification. It is unclear if the variations exist based on 
Black children receiving more appropriate care that is consistent with national guidelines as 
suggested by Fleming-Dutra et al. (2014) or Vernacchio and colleagues’ (2004) suggestion that 
Black and Asian children were less likely to receive specialty care or surgery compared to White 
children with recurrent OM. 
The Impact of OM 
 OM, the inflammation and/or infection of the middle ear, compromises the traditional air-
conduction sound pathway, creating a mild to moderate degree of conductive hearing loss 
(Northern, Downs & Hayes, 2014). OM is delineated as OME or AOM. OME, as defined in the 
clinical practice guideline developed jointly by the American Academy of Otolaryngology – 
Head and Neck Surgery Foundation, the American Academy of Pediatrics, and the American 
Academy of Family Physicians (Rosenfeld et al., 2016), is the presence of fluid in the middle ear 
space without signs or symptoms of an acute ear infection (ear fluid). AOM is the result of rapid 
onset of signs and symptoms of inflammation of the middle ear (ear infection) and typically refers 
to the first few weeks of the pathology being present. Chronic OME develops when OME persists 
for at least three months from the onset date or the diagnosis date of OME (Rosenfeld et al., 
2016).  
Untreated OM may result in short-term implications for the child, including ear pain, 
temporary conductive hearing loss (Northern et al., 2014), or tympanic membrane (eardrum) 
perforation (Bennett et al., 2016; Jung et al., 2013; Klein, 2001; Marom et al., 2014). Repeated 
episodes of OM are costly to both the child and their parents/caregivers. Often, caregivers who 
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work outside of the home need to be absent from their paid job to tend to the child with OM, 
leading to a reduction in their income (Barber et al, 2014). On average, children with AOM have 
twice as many office-based and emergency facility visits compared to same-age peers without 
AOM. In addition, children with AOM receive more than twice the number of prescriptions. This 
results in an increase of $314 per child annually in outpatient health care costs to families and/or 
the US healthcare system (Ahmed et al., 2014).   
Untreated OM may also result in long-term sequelae. Mastoiditis, the second most 
common OM related complication (Marom et al., 2014), occurs as a result of a bacterial infection 
that can cause damage such as inflammation within the temporal bone, meningitis, or a brain 
abscess (Lieberthal et al., 2014; Mattos et al., 2014). Children with repeated or untreated OM may 
experience hearing thresholds that ranges from normal hearing to a moderate hearing loss 
(Rosenfeld et al., 2013). The loss can be conductive in nature due to a stiffening of the tympanic 
membrane and ossicle bones in the middle ear (Grindle & Correa, 2016) or sensorineural, as a 
result of infection or inflammation in the inner ear (Klein, 2001). 
The impact of chronic OM is not limited to audiological damage. Chronic OM often 
results with the child experiencing fluctuating hearing loss over time, thus increasing the risk of 
speech and language delays in young children (Rosenfeld et al., 2013). Fluctuating hearing, 
because of intermittent ear fluid could interfere with speech and language development of 
preschoolers four-years of age or younger (Jung et al., 2013). Deficits have been noted in the 
speech production, speech perception, receptive language, and expressive language skills in 
children with OM (Gravel & Wallace, 2000). Northern et al., (2014) noted speech intelligibility is 
directly proportional to the degree of hearing loss and all children with hearing loss will show 
delays in receptive and expressive language skills. 
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Clefts of the Lip, Palate, or both Lip and Palate 
Clefts of the lip and palate are among the most common of all congenital craniofacial 
anomalies (Parker et al., 2010). Worldwide, it is estimated that clefts of the lip (CL), cleft palate 
(CP), or both the lip and palate (CLP) occur in approximately 1 out of every 600 births 
(Berkowitz, 2013; Dixon et al., 2011; Rahimov et al., 2022). In the US, approximately 7,090 
children are born each year with a cleft of the lip with or without a cleft of the palate (CL/P) 
(Centers for Disease Control and Prevention, 2015) resulting in CL/P occurring in an estimated 1 
per 1,000 live births (Parker et al., 2010; Wehby et al., 2012).    
Individual states are not required to provide data on the number or prevalence rates of 
birth defect cases. According to the National Birth Defects Prevention Network (NBDPN), not all 
states provide statewide data. For example, Georgia only provides metropolitan Atlanta area data 
for children born with CP and CL/P while Minnesota provides such data for children in 
metropolitan Minneapolis (NBDPN, 2017). North Carolina provides statewide data of the number 
of children born with CL, CP, and CLP to the NBDPN (Stallings et al., 2019). Refer to Table 1 
for the average annual number of cases in North Carolina (NC) and the US during 2012-2016.  
 
Table 1. Total Cases of Children Born With CL, CP and CLP in NC and the US  
Total Counts for 2012-2016+ 
Diagnosis NC US 
CL 218 4,797 
CP 307 8,608 
CLP 327 9,799 
Total 852 23,204 
+estimates based on pooled data from birth years 2012-2016 
Prevalence per 10,000 Live Births  
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Previous studies have demonstrated the prevalence of CL/P varies by racial group. 
Generally, individuals of Asian and Native American descent have the highest reported birth 
prevalence rate of CL/P with rates as high as 1 in 500. The prevalence rates of Caucasian children 
are lower with reported rates of nearly 1 out of 1,000; while individuals of African American 
descent were reported to have the lowest rates of roughly 1 out of 2,500 (Arosarena, 2007; Dixon 
et al., 2011; Vanderas, 1987). 
According to Canfield et al. (2006), the prevalence of CL/P also differs according to 
ethnicity. Infants of non-Hispanic Black mothers had a significantly lower birth prevalence of CP 
and CL/P compared to infants of non-Hispanic White mothers. Similarly, infants born to Hispanic 
mothers had a significantly lower birth prevalence of CP compared with infants born to non-
Hispanic White mothers. These results are similar to outcomes obtained by Williams et al. (2003) 
in which the rates of oral clefts were higher in White than in non-Hispanic Black and Hispanic-
White infants. 
OM and CL/P 
Middle ear infection is one of the many conditions that may affect children with CL/P, 
specifically OM with and without effusion. The likelihood of middle ear disease and hearing loss 
in infants with CP has been noted for more than 50 years (Stool & Randall, 1967; Paradise et al., 
1969). OME is generally recognized as a universal complication in children with CP (Paradise, 
1980). More recently, Heidsieck et al., (2016), noted OME continues to occur frequently in 
children with CP. Similarly, Rosenfeld and colleagues (2016) concluded the prevalence of OME 
in children with CP ranges from 60% to 85%. As a result, dysfunction of the Eustachian Tube 
(ET) is believed to be responsible for the majority of OME in individuals with CP (Berkowitz, 
2013). 
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The American Cleft Palate-Craniofacial Association (ACPA) acknowledges children with 
craniofacial anomalies are subject to an increased occurrence of ear disease (ACPA, 2009). 
Children with CL/P have been reported to have significantly increased incidence of Pressure 
Equalization (PE) tubes inserted for management of chronic OM (Flynn et al., 2009; Sheahan et 
al., 2003). Szabo and colleagues (2010) reported 98% of children with CP had at least one set of 
PE tubes inserted by five years of age. Short- and long-term benefits have been reported as a 
result of early insertion of PE tubes in these children (Kuo et al., 2014) including the prevention 
of short-term hearing loss and improved long-term language outcomes (Tunçbilek et al., 2003).  
Treatment for OM 
In the US, there are seven million annual episodes of reported OM with an estimated cost 
of $5 billion (Forrest et al., 2011). Treatment for OM includes nonsurgical and surgical 
interventions. Nonsurgical options include watchful waiting and medical therapy such as steroids, 
antibiotics, antihistamines or decongestants, which provide short-term benefits (Rosenfeld et al., 
2016). When these treatments fail to eliminate chronic OM, the surgical insertion of PE tubes, 
which ventilate the middle ear space, can be used to alleviate the adverse effects of negative 
pressure on middle ear function and provide a means for middle ear fluids from OM to drain 
(Rosenfeld et al., 2013; Wallace et al., 2014).  
Insertion of PE tubes is the most common ambulatory or outpatient surgery performed on 
children in the US (Rosenfeld et al., 2013). By three years of age, nearly 7% or 1 in 15 children 
will have had PE tubes placed (Kogan et al., 2000). Typically, PE tubes are inserted due to 
persistent middle ear fluid, frequent ear infections, or ear infections that persist after antibiotic 
therapy. The insertion of PE tubes reduces the prevalence of effusion, provides a mechanism for 
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drainage, and may reduce the likelihood of recurrent AOM (Browning et al., 2010; Rosenfeld et 
al., 2013). 
Few studies suggest OM is more common in children from lower socioeconomic status 
(SES) families (Ah-Tye, Paradise et al., 2001; Damiano et al., 2009; Paradise et al., 1997). In 
contrast, Lieu and Feinstein (2002) concluded the diagnosis of OM was directly correlated with 
increasing income levels. Thus, SES disparities in the prevalence of OM in children has not been 
thoroughly explored (Smith & Boss, 2010). To fill this gap in the literature, the present study 
compared the prevalence of chronic OM in racial/ethnic minority (REM) and racial/ethnic non-
minority (NM) preschool children with CL/P in the state of NC. The study also compared the 
prevalence of PE tubes in REM and NM preschool children and whether PE tube insertion was 
influenced by the expected payer source of private or public insurance. These findings will 
indicate whether REM preschool children with CL/P and a diagnosis of chronic OM are under-
identified relative to NM preschool children with CL/P and a diagnosis of chronic OM and 
whether they are less likely to get PE tubes. The information gained from this study will assist 
stakeholders including speech-language pathologists, audiologists, medical personnel, educators, 
caregivers, healthcare policymakers/influencers, and when applicable, members of the Cleft 
Palate-Craniofacial Team who are involved in the care of preschool-age children.
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CHAPTER II 
 
LITERATURE REVIEW 
 
It has been reported that racial/ethnic disparities exist in the diagnosis of OM with White 
children more likely to receive a diagnosis of OM compared to children of Black, Asian, and 
Hispanic descent (Fleming-Dutra et al., 2014; Vernacchio et al., 2004). The aim of this literature 
review is to provide an overview of the function of the ET paying special attention to the impact 
on children with clefts of the palate. Next will be a description of OM and CL/P including the 
impact of SES on children with non-syndromic CL/P. Finally, there will be a discussion of access 
to PE tubes, one of the most common treatment options for OM for not only this population but 
for all children.  
Function of the ET and OM 
The function of the ET in the human auditory system includes ventilation, pressure 
regulation, protection from sound, and drainage of secretions in the middle ear (Berkowitz, 2013). 
The ET is normally closed (Sharma & Nanda, 2009). When the ET opens, typically during 
chewing and swallowing, air pressure equalizes between the outer and middle ear, thereby 
ventilating the middle ear. This equalization of the air pressure between the outer and middle ear 
allows optimal transmission of sound through the eardrum. The ability to transmit sound is 
reduced if the air pressure between the outer and middle ear is unequal, forcing the eardrum 
outward or inward, resulting in discomfort (Sharma & Nanda, 2009).  In children younger than 
three years of age. The ET is shorter, floppier, and more horizontal, which makes it less effective 
in ventilating and protecting the middle ear than the ET in the adult (Rosenfeld et al., 2016). 
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An underlying palatopharyngeal musculature contributes to the function of the ET. Thus, 
the primary function of the tensor veli palatini muscle, one of the palatal muscles, is to open the 
ET (Perry, 2011). In individuals with cleft, displacement of muscles due to the palate not fusing 
during fetal development also affects the function of the soft palate. The levator veli palatini 
muscle plays a role in elevating the velum posteriorly, thereby assisting in opening the ET 
(Kuehn & Moller, 2000). In children with CP, the tensor veli palatini has an abnormal course and 
insertions due to defects in the anatomic structure (Broen et al., 1996). Opening of the ET allows 
equalization of air pressure across the eardrum as well as drainage of middle ear fluids to occur 
(Leider et al., 1993). For children with CP, the ET is assumed to be in a horizontal position, 
permitting fluid to freely pass from the oropharynx into the nasopharynx as well as into the ET 
(Rood & Stool, 1981). Children with CP have been found to have severe functional obstruction of 
the ET. This obstruction appears primarily related to the inability of the tensor veli palatini 
muscle to dilate the ET actively during swallowing and seems to be the major factor responsible 
for the pathogenesis of OME in this population (Doyle et al., 1980). This impaired function of the 
ET in children with CLP may increase the risk of frequent ear infections and fluctuation of the 
child’s hearing status over time due to the increased incidence of OM resulting in higher rates of 
mild to severe hearing loss (Kuo et al., 2013).  
It has long been noted that the presence of recurrent OME has been attributed to 
abnormalities of ET function, affecting the child’s hearing ability (Paradise et al., 1969).  
Additionally, children with oral clefts such as clefts of the hard and/or soft palate have an 
increased risk for incidences of ear disease that may be related to structural conditions, which 
affect the function of the ET (ACPA, 2009; Heidsieck, Smarius et al, 2016; Paradise et al., 1969; 
Stool & Randall, 1967). Early intervention and treatment of middle ear disease is vital in reducing 
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or eliminating the potential adverse impact of hearing, social, and psychological effects in 
individuals born with non-syndromic CL/P. 
 In most children, AOM and OME will resolve spontaneously or after medical 
intervention. Children with untreated OM may experience ongoing earache pain (McCormick, 
2016). Rosenfeld and colleagues (2013) noted behavioral complaints such as distractibility, 
withdrawal, frustration, or aggressiveness. Additionally, some children or their caregivers 
reported motor complications including unexplained clumsiness, balance problems, or delayed 
motor development. 
 OM negatively affects sound transmission in the middle ear, possibly increasing the risk 
of speech and language delays in young children (Rosenfeld et al., 2013). Fluctuating hearing as a 
result of intermittent ear fluid could interfere with speech and language development of children 
younger than seven-years (Jung et al., 2013). Although the results have been inconclusive, 
deficits have been noted in the speech production, speech perception, receptive language, and 
expressive language skills in children with OM (Gravel & Wallace, 2000; Northern et al., 2014).  
Cleft Lip and Palate 
Oral-facial clefts (OFC) including CL, CP, and CLP occur early in the first trimester of 
pregnancy, when the child’s lip, palate or other facial structures do not completely fuse (CDC, 
2015). CL and CLP occur either unilaterally or bilaterally. In contrast, CP only appears in the 
midline of the hard and/or soft palate (Peterson-Falzone, 2011). Oral clefts are often categorized 
as either non-syndromic or syndromic type. Non-syndromic or isolated type is the most common 
oral cleft. This type of cleft is not related to a known syndrome or other chromosomal 
abnormalities (Wehby et al., 2014). Individuals with syndromic or non-isolated type of oral clefts 
also present with additional anomalies.   
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People with OFC frequently require healthcare services beyond the initial surgery to 
repair the cleft. In fact, individuals with oral clefts may require medical and dental care from birth 
into adulthood. Furthermore, the effect of an OFC has been identified as having an influence on 
the acquisition of speech sounds (Root, 2012); hearing outcomes (Knight et al., 2015; Skuladottir 
et al., 2015); academic progress and use of special education services (Collett et al., 2014; 
Richman et al., 2012; Wehby et al., 2014; Yazdy et al., 2008). Also, the development of peer 
relationships (Norman et al., 2015; Klein et al. 2014; Wehby et al., 2012) and mental health, 
including issues of body image and self-esteem (Hamlet & Harcourt, 2015; Hunt et al., 2007; 
Stock et al., 2015) have been reported to be impacted with individuals born with an OFC.   
The impact of an OFC is not limited to the individual with the cleft. Even in the presence 
of prenatal diagnosis, the initial parental experience of shock, fear, and the need for emotional 
support may occur. Additional responsibilities and challenges caregivers might face as a result of 
having a child born with an OFC may include parent-child interactions (Nidey et al., 2016; Stock 
& Rumsey, 2015; Zeytinoglu & Davey, 2012), financial costs (Cassell et al., 2008; Razzaghi et 
al., 2015), and demands on time to travel to medical and dental appointments (Cassell et al., 
2014; Cassell et al., 2013). 
The resulting impact of an individual having a CL/P extends beyond the individual and 
their family/caregivers. Individuals with a CL/P also have an influence on society as a whole. 
Individuals with OFC typically require ongoing medical interventions to minimize developmental 
complications that occur later in life (Phua et al., 2009; Weiss et al., 2009). Financial costs extend 
beyond the toddler years for children with CL/P to include salaries for teachers and clinicians to 
provide academic support (Cassell et al., 2014; Wehby et al., 2014), as well as speech and 
language services (Wehby et al., 2012; Yazdy et al., 2008). Increased attention has focused on the 
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need to provide mental health support to address overall health and quality of life for individuals 
with CL/P (Munz et al., 2011; Sinko et al., 2005; Stock et al., 2015; Strauss & Cassell, 2009).  
The Impact of SES and CL/P 
Inconsistent findings have been reported on the impact of SES and CL/P. In a nationwide 
study of infants born during 1997-2000, researchers concluded children from households with the 
lowest SES had the greatest risks of being born with CL/P (Yang et al., 2008). Similarly, 
Carmichael et al., (2009) noted lower SES was associated with an increased risk of CL/P and CP. 
On the other hand, discrepant results were obtained in a study conducted by Root (2012), in 
which SES did not affect the likelihood of a child being born with CL/P as determined by the 
poverty and unemployment rates of the neighborhood. 
Access to PE Tube Treatment 
 PE tube insertion is the most common ambulatory or outpatient surgery performed on 
children in the US (Rosenfeld et al., 2013). This procedure is typically performed because of 
persistent middle ear fluid, frequent ear infections or ear infections that persist after antibiotic 
therapy (Rosenfeld et al., 2013). This cost-effective treatment for OM costs on average $769 per 
surgery as determined by Sjogren and colleagues (2016). 
Research over the past twenty years has shown that intervention for OM with PE tube 
treatment differs by race, with White children being more likely than Black children to receive 
this surgical procedure (Fleming-Dutra et al., 2014). White children and children in the South 
region of the US were more likely to receive PE tube treatment by three years of age, compared 
with African American/Black children (Kogan et al., 2000). Simon and colleagues (2017) 
reported similar results in that it was more common for White children to receive PE tube 
insertion surgery compared to Black and Hispanic children. Furthermore, African 
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American/Black children were less likely to receive surgical or antibiotic treatment compared to 
White children. Thus, disparities in access to PE tubes exists due to the structure of the respective 
healthcare systems and social factors, including access to regular care and insurance type (Baerg 
et al., 2017). 
Medicaid, a joint federal and state program, is the single largest source of health coverage 
in the United States. The Children’s Health Insurance Program (CHIP) serves uninsured children 
in families with incomes too high to qualify for Medicaid. Combined these two programs provide 
health coverage to more than 72.5 million Americans (Centers for Medicare & Medicaid 
Services, n. d). The Patient Protection and Affordable Care Act (Affordable Care Act) which was 
signed into law in March 2010 included provisions on affordable healthcare. By 2016, it was 
estimated an additional 20 to 24 million people were insured as a result of this Act (Uberoi et al., 
2016). 
The cost of inserting PE tubes may be a prohibitive factor for some uninsured families. 
For 2016, the federal poverty threshold level for a family of four with two children was $24,339. 
In NC of the 2,241,156 children living in the state 532,742 or 24% were living with poor families, 
compared to the national average of 19%. The race/ethnicity of these children living in poor 
families were 14% White, 37% Black, 12% Asian, 36% Native American, and 40% Hispanic. To 
sum up, 27% of all children under the age of 6-years lived in poor families in the state, according 
to the National Center for Children in Poverty (n.d.). 
The Impact of Socioeconomic Disparities and PE Tube Treatment 
 Individuals from low SES backgrounds often experience barriers to accessing many types 
of healthcare in the US, resulting in substantial healthcare disparities (Bornstein et al., 2010; Like, 
2011; Roseberry-McKibbin, 2000). Researchers have reported that children with chronic OME 
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were more likely to be from high poverty areas or lower neighborhood median household income 
levels. On the other hand, children from neighborhoods that experienced lower incidences of 
poverty or higher neighborhood median household income levels were more likely to receive PE 
tubes for recurrent AOM. Researchers also noted children with recurrent AOM were more likely 
to be privately insured compared to those who were publicly insured (Nieman et al., 2016).  
In the US, disparities in the prevalence of OM in children have not been thoroughly 
explored (Smith & Boss, 2010). Few studies suggest OM is more common in children from lower 
SES families (Ah-Tye, Paradise et al., 2001; Damiano et al., 2009; Paradise et al., 1997). In 
contrast, Lieu and Feinstein (2002) concluded the diagnosis of OM was directly correlated with 
increasing income levels.   
 It has long been reported that children with CL/P have an increased risk for incidences of 
OM (Paradise et al., 1969). Previous research has reported conflicting results of the impact of 
SES and the diagnosis of OM in children. While studies have demonstrated Black children are 
less likely to be diagnosed with OM and receive surgery for PE tube insertion (Fleming-Dutra et 
al., 2014), few studies have explored the access REM children with CL/P have to this hearing 
healthcare intervention. 
Purpose of the Current Research 
 The purpose of this study was to examine the prevalence of middle ear disease, 
specifically chronic OM. Also, the probability of being born with non-syndromic CL, CP, CLP in 
preschool-age REM children in NC was explored. In addition, the likelihood of REM children 
with CL/P being diagnosed with chronic OM and then receiving PE tube treatment was 
investigated. Finally, this study will report any differences of PE tube treatment in NM and REM 
children with CL/P based on the expected payer source. Files from the State Ambulatory Surgery 
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and Services Databases (SASD) of the Healthcare Cost and Utilization Project (HCUP) sponsored 
by the Agency for Healthcare Research and Quality (AHRQ) (AHRQ, 2016) were analyzed. 
The specific research questions and hypotheses are listed below:     
1.  Are there significant differences in the prevalence of chronic OM in NM and REM preschool-
age children? 
Hypothesis: REM preschool-age children are less likely to be diagnosed with chronic OM 
than NM preschool-age children. 
2.  Are there significant differences in the prevalence of CL, CP, and CLP in NM and REM 
preschool-age children? 
Hypothesis: REM preschool-age children are more likely to be diagnosed with CL than 
NM preschool-age children whereas REM preschool-age children will be less likely to be 
diagnosed with CP and CLP than NM preschool-age children. 
3. Are there significant differences in the prevalence of chronic OM in NM and REM preschool-
age children with diagnoses of CP and CLP? 
Hypothesis: REM preschool-age children with CP and CLP are less likely to be 
diagnosed with chronic OM than NM preschool-age children with CP and CLP. 
4.  Are there significant differences in the prevalence of receiving PE tube treatment in NM and 
REM preschool-age children with diagnoses of CP and CLP?  
Hypothesis: REM preschool-age children with CP and CLP are less likely to receive PE 
tube treatment than NM preschool-age children with CP and CLP. 
5.  Are there significant differences in the expected payer source for PE tube treatment for NM 
and REM preschool-age children with CP and CLP?  
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Hypothesis: NM preschool-age children are more likely to have an expected private payer 
source (private insurance) for PE tube treatment than REM preschool-age children 
whereas REM preschool-age children are more likely to have an expected public payer 
source (e.g. Medicare, Medicaid, no charge, etc.) for PE tube treatment than NM 
preschool-age children. 
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CHAPTER III 
 
METHOD 
 
The overall purpose of this study was an examination of the prevalence of middle ear 
disease, specifically chronic OM in NM and REM preschool-age children in North Carolina. In 
addition, the likelihood of NM and REM children with non-syndromic CL, CP, CLP being 
diagnosed with chronic OM and then receiving PE tube treatment was investigated. Finally, the 
use of PE tube treatment in NM and REM children with CL/P based on the expected payer source 
was explored. The study was reviewed and approved by the University of North Carolina 
Greensboro Institutional Review Board. Data were purchased and obtained through data use 
agreement with HCUP and the AHRQ.  
Secondary Data Files 
Existing data was derived from restricted use files from the SASD of HCUP sponsored 
by the AHRQ (AHRQ, 2016). HCUP is part of a federal, state, and industry partnership 
sponsored by the AHRQ and includes information from inpatient and outpatient hospitals. Thirty-
five participating states and the District of Columbia voluntarily report patient-level hospital stay 
data to HCUP following the standardized International Classification of Diseases, Tenth 
Revision, Clinical Modification (ICD-10-CM) codes. HCUP includes the largest collection of 
longitudinal hospital care data in the US and includes all-payer types (AHRQ, 2016). The SASD 
is comprised of encounter data, or information on the services provided, for ambulatory surgery 
as well as other outpatient services from hospital-owned facilities. This dataset includes 
aggregated clinical and demographic information including the patient’s age on the procedure 
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date, gender, racial/ethnic identity, payer type, zip codes, and medical diagnoses for patients 
(AHRQ, 2016). 
Study Design 
 SASD data for North Carolina was accessed and analyzed. A descriptive quantitative 
design was used for this records review study. The design was non-experimental and cross-
sectional. This research was completed using the most recent de-identified data provided from 
HCUP. Relevant ICD-10-CM codes were identified from inpatient and outpatient hospital visits 
of preschool-aged children during the 2016 calendar year. 
Participants and Coding 
 The analysis was limited to children birth to five-years, 11-months of age who received 
medical care in NC as reported to the HCUP program during 2016. A total of 319,682 patient 
files were accessed for the study. Patients with a primary diagnosis of CL/P were identified using 
ICD-10-CM codes for cleft lip and cleft palate. The use of these primary ICD-10-CM oral cleft 
codes was to control for non-syndromic CL/P. Refer to Table 2 for additional details on ICD-10-
CM codes used to identify children with CL/P.  
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Table 2. ICD-10-CM Codes for Cleft Lip and Cleft Palate 
 
Q35 Cleft Palate 
Q35.1  Cleft hard palate 
Q35.3  Cleft soft palate 
Q35.5  Cleft hard palate with cleft soft palate 
Q35.9 Cleft palate, unspecified 
Q36 Cleft Lip 
Q36.0 Cleft lip, bilateral 
Q36.1 Cleft lip, median 
Q36.9 Cleft lip, unilateral 
Q37 Cleft Palate with Cleft Lip 
Q37.0 Cleft hard palate with bilateral cleft lip 
Q37.1 Cleft hard palate with unilateral cleft lip 
Q37.2 Cleft soft palate with bilateral cleft lip 
Q37.3 Cleft soft palate with unilateral cleft lip 
Q37.4 Cleft hard and soft palate with bilateral cleft lip 
Q37.5 Cleft hard and soft palate with unilateral cleft lip 
Q37.8 Unspecified cleft palate with bilateral cleft lip 
Q37.9 Unspecified cleft palate with unilateral cleft lip 
 
ICD-10-CM codes H65 (Nonsuppurative otitis media) and H66 (Suppurative and 
unspecified otitis media) were used to identify children with diseases of middle ear and mastoid 
process. The 80 codes were categorized as either acute or chronic OM. Northern et al., (2014) 
stated chronic suppurative OM is long-term and recurrent; for this reason, suppurative OM was 
identified as chronic and nonsuppurative OM as acute. See Appendix A for a complete list of all 
ICD-10-CM codes for diseases of middle ear and mastoid process. Table 3 presents the Current 
Procedural Terminology (CPT) procedure codes (Centers for Medicare & Medicaid Services, 
2004) used to identify the PE tube treatment. 
 
Table 3. Description of CPT Codes  
 
Code Diagnostic Service for PE tube insertion surgery 
69433 Tympanostomy (requiring insertion of ventilating tube), local or topical 
anesthesia   
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 
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Data Extraction 
The data was purchased through the HCUP Central Distributor after completing a web 
based HCUP Training Course and Data Use Agreements with the AHRQ. The database was 
delivered via computer disc. The study data included racial/ethnic identification, expected payer 
source, diagnosis of CL/P, diagnosis of diseases of middle ear, CPT codes for the tympanostomy 
procedure, and the patient’s zip code of residence. Case information on 319,682 patient files were 
extracted from SASD’s software using a coding system (See Appendix B) and then saved on an 
SPSS spreadsheet.  
Variables of interest for the study were identified from the SASD database. Recoding of 
data allowed grouping of ICD-10-CM codes that contained a greater level of detail; therefore, a 
group of conditions were transformed into one code. For example, the three ICD-10-CM codes 
used to identify bilateral CL (Q36.0), median CL (Q36.1), or a unilateral CL (Q36.9) were 
collapsed into one variable (DX_Cleft Lip). Recoding was also performed for the 80 ICD-10-CM 
codes to identify a diagnosis of acute or chronic OM; four ICD-10-CM codes to identify a 
diagnose of CP; eight ICD-10-CM codes to identify a diagnose CLP; two CPT codes to identify 
PE tube treatment (tympanostomy surgery); NM or REM identification, and the expected primary 
payer source of private (private insurance or self-pay) or public (Medicare, Medicaid, no charge, 
or other government programs) insurance. The data was saved on UNCG Box.   
Descriptive Characteristics of the Sample 
A total of 319,682 children birth to five-years, 11-months of age received medical care in 
NC during 2016 as reported to the HCUP program and identified in the SASD database. It is 
important to note that children could have participated in multiple visits in the same calendar 
year; however, that information was not contained in this dataset. Table 4 lists the demographic 
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data accessed for this study. There were 176,914 male (55.3%) participants in this study (Figure 
1). With respect to racial/ethnic identification, 164,347 (51.4%) subjects identified as NM. There 
were 19,663 (6.2%) cases missing racial/ethnic identification (Figure 2). No REM child with 
chronic OM had a diagnosis of CL, whereas 45.5% of REM children diagnosed with chronic OM 
had CLP. A total of 15,631 (4.9%) of medical care visits were for PE tube treatment. Public 
insurance was the expected primary payer source for 207,597 (64.9%) of the children.  
 
Table 4. Selected Characteristics of Preschool-Age Children Who Received Medical Care in 
NC in 2016 
 
Characteristic                                                           n                                                          % 
Racial/Ethnic Identification 
          NM  164,347           51.4 
          REM 135,672           42.4 
          Missing   19,663             6.2 
CL/P Diagnoses 
          CL Diagnosis        131                 < 0.01 
          CP Diagnosis        337                 < 0.01 
          CLP Diagnosis        382                  < 0.01 
OM Diagnoses   
          Acute OM     7,662             2.4 
          Chronic OM   17,757                        5.6 
Procedure 
          PE Tube Treatment     15,631                    4.9 
Expected Primary Payer Source 
          Private Insurance   110,599            34.6 
          Public Insurance    207,597             64.9 
          Missing     1,486               .5 
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Figure 1. Children by Gender Identification 
 
 
 
Figure 2. Children by Racial/Ethnic Identification 
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Access to Medical Care 
Most of the medical care provided was to residents of NC. The North Central (26.4%), 
Piedmont-Triad (20.0%), and Southwest (18.0%) regions had the most preschool-age children to 
receive medical services; whereas, the Northeast (3.9%), Northwest (6.2%), and Western (6.3%) 
regions had the least number of children accessing medical care. These geographical regions were 
selected as the expectation would be for children to enroll in a public, charter, private, or non-
public (homeschool) setting within one of the eight educational regions of the NC State Board of 
Education Districts, based on the zip code of their residence. 
Access to medical services was not restricted to residents of NC. Of the preschool-age 
children who received medical care, approximately 8,300 (2.5%) resided outside of the state or 
country. Table 5 lists the range of the number of medical care visits for the preschool-age 
children who were non-residents of NC. Of the children who lived in one of the 46 states, 
territories or another country, many lived in the neighboring states of Virginia (2,463) or South 
Carolina (4,293). 
 
Table 5.  Range of Number of Medical Care Visits for Non-Residents of NC 
 
Number of medical  
care visits 
Residential State or Territory Within the US 
1-25 
 
 
 
 
 Alaska, Alabama, Arizona, Colorado, Connecticut, District of 
Columbia, Hawaii, Indiana, Iowa, Kansas, Kentucky, Louisiana, 
Maine, Massachusetts, Michigan, Mississippi, Missouri, Nebraska, 
New Hampshire, New Mexico, North Dakota, Oklahoma, Oregon, 
Puerto Rico, Rhode Island, South Dakota, Utah, Vermont, Washington, 
Wisconsin                                                                        
26-50  Arkansas, Illinois, Ohio, Pennsylvania 
51-75  California, Minnesota, Texas 
76-100  New Jersey 
101-150  Georgia, Maryland, Tennessee, West Virginia 
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Table 5. Cont. 
 
Number of medical 
care visits 
Residential State or Territory Within the US 
151-200  Florida, New York 
1,000-2,000  Invalid/Missing 
2,000-4,000  Virginia 
4,001-5,000  South Carolina 
Number of medical  
care visits 
Country of Residence 
1-25  Brazil      
 
Data Analysis 
For each research question, prevalence data or the total number of children with the 
existing condition (e.g. chronic OM, CL/P, PE tube treatment, private or public insurance) was 
calculated to determine the likelihood of the condition or situation occurring. The number of 
children in the sample with the characteristic of interest (e.g. children with a diagnosis of chronic 
OM) was divided by the total number of children in the sample (children with and without 
chronic OM) to determine the prevalence. Next the odds ratio with 95% confidence intervals 
were calculated. Odds ratio represent the strength of exhibiting the characteristic compared to the 
odds of not having the characteristic. Odds ratio compares the relative odds of the occurrence of 
the outcome (e.g. diagnosed with chronic OM) given the variable of interest (e.g., REM). An 
odds ratio = 0 indicates the variable does not affect odds of outcome. Odds ratio > 1 suggest the 
associated variable has higher odds of outcome; whereas an odds ratio < 1 implies lower odds of 
outcome. Binary logistic regression analyses were used to determine whether the odds ratio was 
significant. A p-value < 0.05 was the criteria for statistical significance. 
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CHAPTER IV 
 
RESULTS   
 
The first research question addressed the prevalence of chronic OM in NM and REM 
preschool-age children. Chronic OM was diagnosed in 16,915 (6%) of the 300,019 children with 
racial/ethnic information. Due to missing racial/ethnic identification, this number is lower than 
the overall number of children in the study. As can be seen in Figure 3 and Table 6, there were 
12,129 NM and 4,786 REM children diagnosed with chronic OM. The prevalence for chronic 
OM in NM children was .074 (12,129/164,347) compared with .035 for REM children 
(4,786/135,672). The odds ratio was 2.18, indicating NM children were twice as likely to be 
diagnosed with chronic OM than REM children. A binary logistic regression analysis indicated 
that this difference was significant (p < .001) (Table 7).  
 
Figure 3. Diagnoses of Chronic OM by Racial/Ethnic Identification 
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Table 6. Children Diagnosed With Chronic OM by Racial/Ethnic Identification 
                     NM                            REM Total 
No diagnosis 
of chronic OM 
 
  152,218 
 
130,886 
 
283,104 
Diagnosis of 
chronic OM 
 
12,129 
 
4,786 
 
16,915 
Total 164,347 135,672 300,019 
Prevalence for 
diagnosis of 
chronic OM 
 
 
12,129 / 164,347 = .0738   
 
 
4,786 / 135,672 = .0353  
 
 
 
Table 7. Odds of Receiving a Diagnosis of Chronic OM According to Racial/Ethnic 
Identification 
 
     95% CI 
 B S.E. p - value Odds Ratio Lower Upper 
Race/Ethnicity .779 .017 < .001 2.18 2.106 2.255 
Constant -3.309 .015 < .001 .037   
 
The second research question addressed the prevalence of CL, CP and CLP in NM and 
REM preschool-age children. A total of 850 children had CL/P. CL was diagnosed in 131 of the 
children; however, due to 22 cases missing racial/ethnic identification, only 109 of the children 
with CL included racial/ethnic identification. NM children were diagnosed with 56 cases of CL 
and REM children were diagnosed with 53 cases of CL. Of the 337 children diagnosed with CP, 
40 were missing racial/ethnic identification. NM children were diagnosed with 207 cases of CP 
while REM children were diagnosed with 90 cases of CP. Similarly, 40 children with CLP were 
missing racial/ethnic identification. There were 211 NM children diagnosed with CLP and REM 
children were diagnosed with 131 cases of CLP (Figure 4).  
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Figure 4. Children by CL/P and Racial/Ethnic Identification 
 
 
 
As can be seen in Table 8, the prevalence for NM children being diagnosed with CL was 
.0003 (56/164,347) compared with .0004 (53/135,672) for the REM children. The odds ratio was 
1.15 indicating that the two groups were equally likely to be diagnosed with CL. The difference 
was not significant (p > .05) (Table 9).    
 
Table 8. Children Diagnosed With CL by Racial/Ethnic Identification 
 
                    NM                          REM                     Total 
No diagnosis of 
CL 
  
164,291 
 
135,619 
 
299,910 
Diagnosis of CL 56 53 109 
Total 164,347 135,672 300,019 
Prevalence for 
diagnosis of CL 
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53 / 135,619 = .00039 
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Table 9. Odds of Receiving a Diagnosis of CL According to Racial/Ethnic Identification 
     95% CI 
 B S.E. p - value Odds Ratio Lower Upper 
Race/ 
Ethnicity 
 
.137 
 
.192 
 
.476 
 
1.147 
 
.787 
 
1.669 
Constant -7.984 .134 < .001 .000   
 
As can be seen in Table 10, the prevalence for NM children being diagnosed with CP was 
.0013 (207/164,347) compared to .0007 (90/135,672) for the REM children. The odds ratio was 
1.90, indicating NM children were about twice as likely to be diagnosed with CP than REM 
children. This difference was significant (p < .001) (Table 11).    
 
Table 10. Children Diagnosed With CP by Racial/Ethnic Identification 
 
                        NM                        REM            Total 
No diagnosis of CP 164,140 135,582 299,722 
Diagnosis of CP 207 90 297 
Total 164,347 135,672 300,019 
Prevalence for 
diagnosis of CP 
 
207 / 164,347 = .00126 
 
90 / 135,582 = .00066  
 
 
 
Table 11. Odds of Receiving a Diagnosis of CP According to Racial/Ethnic Identification 
 
     95% CI  
 B S.E. p - value Odds Ratio Lower Upper 
Race/ 
Ethnicity 
 
.642 
 
.126 
 
  < .001 
 
1.90 
 
1.483 
 
2.434 
Constant -7.318 .105 < .001 .001   
 
Table 12 provides the prevalence data for CLP. As can be seen in this table, the 
prevalence for NM children being diagnosed with CLP was .0012 (211/164,347) compared to 
.001 (131/135,672) for the REM children. The odds ratio was 1.3, which means the NM children 
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were about 30% more likely to be diagnosed with CLP than the REM children. This higher 
likelihood, though small, was significant (p < .05) (Table 13).   
 
Table 12. Children Diagnosed With CLP by Racial/Ethnic Identification 
 
              NM                  REM 
No diagnosis of CLP 164,136 135,541 
Diagnosis of CLP 211 131 
Total 164,347 135,672 
Prevalence for diagnosis of CLP 211 / 164,347 = .00128 131 / 135,672 = .00097 
 
 
Table 13. Odds of Receiving a Diagnosis of CLP According to Racial/Ethnic Identification 
 
     95% CI  
 B S.E. p - value Odds Ratio Lower Upper 
Race/ Ethnicity .285 .111    .010 1.330 1.069 1.654 
Constant -6.942 .087 < .001 .001   
 
The third research question addressed the prevalence of chronic OM in NM and REM 
preschool-age children with a diagnosis of CP and CLP. Only one NM child had a diagnosis of 
CL and chronic OM, so the analyses in this section focuses on CP and CLP. As shown in Table 
14, there were 207 NM and 90 REM children diagnosed with CP. The prevalence for chronic OM 
in NM children with CP was .145 (30/207) compared to .122 for REM children (11/90). The odds 
ratio was 1.22, indicating NM children were 22% more likely to be diagnosed with chronic OM 
than REM children. This difference was not significant (p > .05) (Table 15).  
 
Table 14. Children Diagnosed With CP With and Without Chronic OM  
 
 NM children with CP REM children with CP 
Diagnosed with chronic OM  30 11 
No diagnosis of chronic OM 177 79 
Total  207 90 
Prevalence for diagnosis  
of chronic OM 
 
30 / 207 =.1449  
 
11 / 90 = .1222  
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Table 15. Odds of Receiving a Diagnosis of Chronic OM by CP Diagnosis 
 
     95% CI  
 B S.E. p - value Odds Ratio Lower Upper 
Race/ 
Ethnicity 
 
.197 
 
.378 
 
.603 
 
1.217 
 
.581 
 
2.551 
Constant -1.972 .322 < .001 .139   
 
 Table 16 shows that the prevalence for the NM children being diagnosed with CLP was 
.114 (24/211) compared to .153 (20/131) for the REM children. REM children with CLP were 
40% more likely to be diagnosed with chronic OM than NM children with CLP. As can be seen 
in Table 17, the difference was not significant (p > .05). 
 
Table 16. Children Diagnosed With CLP With and Without Chronic OM 
 
 NM children with CLP REM children with CLP 
Diagnosed with chronic OM  24 20 
No diagnosis of chronic OM 187 111 
Total  211 131 
Prevalence for diagnosis  
of chronic OM 
 
24 / 211 = .1137  
 
20 / 131 = .1527  
  
 
 
Table 17. Odds of Receiving a Diagnosis of Chronic OM by CLP Diagnosis 
 
    95% CI 
 B S.E. p - value Odds Ratio Lower Upper 
Race/ 
Ethnicity 
 
-.339 
 
.326 
 
.297 
 
1.404 
 
.742 
 
2.658 
Constant -2.053 .217 < .001 .128   
 
The fourth research question addressed the prevalence of receiving PE tube treatment in 
NM and REM preschool-age children with diagnoses of CP and CLP. As can be seen in Table 18 
and Table 19, there were 12 NM and 7 REM children diagnosed with CP who received PE tube 
treatment. The prevalence for receiving PE tubes in NM children with CP was .058 (12/207) 
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compared to .078 for REM children (7/90). The odds ratio was 1.37, indicating REM children 
with CP were 37% more likely to receive PE tubes than NM children. The difference was not 
significant (p > .05) (Table 19). 
 
Table 18. Children Diagnosed With CP and Receiving PE Tube Treatment 
 
 NM children with CP REM children with CP 
No PE tube treatment  195 83 
PE tube treatment  12 7 
Total  207 90 
Prevalence for receiving  
PE tube treatment 
 
12 / 207 = .058  
 
7 / 90 = .0778  
 
Table 19. Odds of Receiving PE Tube Treatment by CP Diagnosis 
 
     95% CI 
 B S.E. p - value Odds Ratio Lower Upper 
Race/ Ethnicity .315 .493 .523 1.370 .521 3.604 
Constant -2.788 .297 < .001 .062   
 
 Table 20 shows that the prevalence for NM children with CLP receiving PE tube 
treatment was .076 (16/211) compared to .038 (5/131) for the REM children with CLP. The odds 
ratio was 2.07 indicating NM children with CLP were twice as likely to receive PE tube treatment 
than REM children with CLP. As can be seen in Table 21, although preschool NM children were 
twice as likely to receive PE tubes treatment than REM children, the difference was not 
significant (p > .05). 
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Table 20. Children Diagnosed With CLP and Receiving PE Tube Treatment 
 
 NM children with CLP REM children with CLP 
No PE tube treatment  195 126 
PE tube treatment  16 5 
Total  211 131 
Prevalence for receiving  
PE tube treatment 
 
16 / 211 = .0758  
 
5 / 131= .0382  
 
Table 21. Odds of Receiving PE Tube Treatment by CLP Diagnosis 
 
    95% CI 
 B S.E. p - value Odds Ratio Lower Upper 
Race/ Ethnicity .726 .525 .166 2.068 .739 5.785 
Constant -3.227 .456 < .001 .040   
 
The fifth research question addressed the prevalence of the expected payer source for NM 
and REM preschool-age children with CP or CLP receiving PE tube treatment. As shown in 
Table 22, there were 10 NM and two REM children with CP or CLP who received PE tube 
treatment with the expected payer source of private insurance. The prevalence for private 
insurance paying for PE tube treatment in NM children with CP or CLP was .357 compared to 
.167 for REM children. This odds ratio was 1.755 indicating NM children with CP or CLP who 
received PE tubes were more likely to have private insurance than REM children. The difference 
was not significant (p = > .05) (Table 23).  
There were 18 NM and 10 REM children with CP or CLP who received PE tube 
treatment with the expected payer source of public insurance (Table 22). The prevalence for 
public insurance paying for PE tube treatment in NM children with CP or CLP was .643 
compared to .833 for REM children. The odds ratio was 1.373 indicating NM children with CP or 
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CLP who received PE tubes were more likely to have public insurance than REM children. The 
difference was not significant (p = > .05) (Table 24).     
 
Table 22. Children Diagnosed With CP or CLP Who Received PE Tube Treatment by 
Payer Source 
 
 NM children with CP or CLP REM children with CP or CLP 
Private Insurance 10 2 
Public Insurance  18 10 
Total  28 12 
Prevalence for private 
insurance as expected  
payer source 
 
 
10 / 28 = .3571 
 
 
2 / 12 = .1667 
Prevalence for public 
insurance as expected  
payer source  
 
 
18 / 28 = .6429 
 
 
10 / 12 = .8333 
 
Table 23. Odds of Being Diagnosed With CP or CLP and Receiving PE Tube Treatment by 
Private Payer Source  
 
     95% CI 
 B S.E. p - value Odds Ratio Lower Upper 
Race/ Ethnicity .563 .788 .475 1.755 .375 8.220 
Constant -2.976 .324 .000 .051   
 
Table 24. Odds of Being Diagnosed With CP or CLP and Receiving PE Tube Treatment by 
Public Payer Source  
 
     95% CI 
 B S.E. p-value Odds Ratio Lower Upper 
Race/ Ethnicity .317 .406 .435 1.373 .620 3.040 
Constant -2.976 .324 .000 .051   
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CHAPTER V 
 
DISCUSSION 
 
Summary of Findings 
Five research questions were examined in this study. The first one questioned the 
prevalence of chronic OM in NM and REM preschool-age children. It was hypothesized that 
REM children would be less likely to be diagnosed with chronic OM than NM children. NM 
children were more than twice as likely to be diagnosed with chronic OM than REM children. 
These results indicate REM children were significantly less likely to be diagnosed with chronic 
OM than NM children. The results are consistent with previous research showing fewer REM 
children are diagnosed with chronic OM than NM children (e.g., Fleming-Dutra et al., 2014; 
Smith & Boss, 2010).  
The second research question addressed the prevalence of CL, CP, and CLP in NM and 
REM preschool-age children. It was hypothesized that REM children would be more likely to be 
diagnosed with CL than NM children. Previous research reported the prevalence rates for children 
of Asian and Native American descent were the highest, with Caucasian children higher than 
those of African American descent (Arosarena, 2007; Dixon et al., 2011; Vanderas, 1987). The 
data set analyzed for this study combined African American/Black, Asian or Pacific Islander, 
Native American and Hispanic as REM. In the current study, though not statistically significant, 
REM children were diagnosed with CL at a slightly higher rate than NM children. It was also 
hypothesized REM children would be less likely to be diagnosed with CP and CLP than NM 
children. Statistically significant results found NM children were more likely to be diagnosed 
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with CP (about twice as likely) and CLP (approximately 30% higher) than REM children. These 
results agree with those of Canfield and colleagues (2006) in which infants of non-Hispanic Black 
mothers had significantly lower birth prevalence of CP and CLP compared to infants of non-
Hispanic White mothers. Likewise, Williams et al., (2003) reported rates of oral clefts were 
higher in White infants compared to non-Hispanic Black and Hispanic-White infants. 
The third research question investigated the prevalence of chronic OM in NM and REM 
preschool-age children with diagnoses of CP and CLP. It was hypothesized REM children with 
CP and CLP would be less likely to be diagnosed with chronic OM than NM children with CP 
and CLP. Only one child with CL was diagnosed with chronic OM. Although 20% more NM 
children with CP were diagnosed with chronic OM than REM children, the results were not 
significant. NM children with CLP were more likely (40%) to be diagnosed with chronic OM 
than REM children; however, the results were not significant. This could be because of the small 
number of children with CP and CLP diagnosed with chronic OM. 
The fourth research question probed the prevalence of receiving PE tube treatment in NM 
and REM preschool-age children with diagnoses of CP and CLP. It was hypothesized REM 
children with CP and CLP would be less likely to receive PE tube treatment than NM children 
with CP and CLP. Though not significant, approximately 37% more REM children with CP 
received PE tubes compared to NM children with CP. Fewer than 15 children with CP received 
PE tubes and less than 20 children with CLP received PE tubes. Although numerically the NM 
children received more PE tube treatment than REM children, statistically REM children were 
more likely to receive PE tubes. The results differ from Fleming-Dutra et al., (2014) in which 
White children were more likely than Black children to receive PE tubes.  
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The final research question explored the expected payer source for PE tube treatment for 
NM and REM preschool-age children with CP or CLP. It was hypothesized NM children would 
be more likely to have an expected private payer source for PE tube treatment than REM 
children. Even though NM children with CP or CLP who received PE tube treatment had private 
insurance as the expected payer source 37% more than REM children, the results were not 
significant. It was also hypothesized REM children with CP or CLP would be more likely to have 
an expected public payer source for PE tube treatment than NM children. Although REM children 
were 75% more likely to have public insurance as the expected payer source than NM children, 
the results were not significant. Whereas there were 30 NM children with CP or CLP who 
received PE tube treatment, fewer than 15 REM children with CP or CLP received PE tube 
treatment. 
Interpretation of Study Findings and Practice Implications 
Disparities in healthcare treatment outcomes have historically occurred with groups that 
actually or perceptually vary from the expected norms or group that typically represents the 
majority. Therefore, variations from expected norms can occur with racial/ethnic identification or 
SES (Carter-Pokras, & Baquet, 2002). It has been projected that by 2044, more than half of all 
Americans will not identify as racial/ethnic non-minorities (US Bureau, 2015); as a result, the 
racial/ethnic diversity of US residents, including preschool-age children is expected to continue to 
increase.  
This study confirmed an area of disparity related to the hearing healthcare of NM and 
REM preschool-age children. REM children in NC were less likely to be diagnosed with chronic 
OM than NM children, indicating REM children are under-identified in the diagnosis of chronic 
OM. Additionally, REM children in NC have a lower risk of being born with CP and CLP. These 
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results are consistent with previously reported racial/ethnic variation in the occurrence of CL/P 
(Arosarena, 2007; Dixon et al., 2011; Vanderas, 1987).   
A crucial step in eliminating the disparate outcomes for racial/ethnic minority children is 
to acknowledge the existence of disparities and collectively work towards finding solutions to 
ensure all children receive quality care based on implementation of respective clinical practice 
guidelines. Perhaps the explanation is found in social factors, such as access to care, reporting of 
the severity of symptoms, or complying with medical recommendations. There may be 
misunderstandings by caregivers (biological parents, legal guardians, foster parents, immigrants, 
refugees, etc.) in reporting the presence of concerns; as well as, the frequency and severity of 
symptoms. These miscommunications may result in over- or under-reporting of symptoms, 
leading to racial/ethnic disproportionate diagnosis for chronic OM. On the other hand, if 
stakeholders including caregivers, speech-language pathologists, audiologists, medical personnel, 
educators, and healthcare policymakers are mindful of these issues, accurate caregiver reporting 
and when appropriate, questioning of children’s symptoms may reduce over- or under-referrals 
for chronic OM, thereby increasing accurate diagnosis and effective treatment. Given these 
points, stakeholders should make a concerted effort to identify at-risk children regardless of their 
racial/ethnic identification or socioeconomic factors. The Clinical Practice Guideline: Otitis 
Media with Effusion (Rosenfeld et al., 2016) suggests multidisciplinary recommendations 
including evaluating at-risk children for OM at the time of diagnosis of an at-risk condition; 
providing education for caregivers regarding the natural history of OM and the need for follow-
up; and recommending PE tube treatment when appropriate.  
The impact of not receiving early hearing healthcare intervention may negatively impact 
the child’s educational future. Also, the effects of an OFC may influence acquisition of speech 
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sounds (Root, 2012); academic progress; and use of special education services (Collett et al., 
2014; Richman et al., 2012; Wehby et al., 2014; Yazdy et al., 2008). Preschool-age children may 
experience temporary or permanent hearing loss due to not receiving early hearing interventions; 
such as PE tubes, in a timely manner. Reduced hearing can also interfere with appropriate 
opportunities of stimulation, social development, and pre-literacy skills, which are all 
instrumental for developing school readiness. As a result, these children will be at greater risk 
academically. School districts are responsible for obtaining and allocating financial resources to 
hire and/or train personnel to remediate these delays. In NC the financial burdens of caring for 
those children who are at greater risk based on previous diagnoses of OM or CL/P, are 
concentrated in the North Central, Piedmont-Triad and the Southwest educational regions of the 
NC State Board of Education Districts. Four of the five Cleft Palate-Craniofacial Teams located 
in the state are within these three educational regions (ACPA, 2020). The remaining Cleft Palate-
Craniofacial Team is in the Southeast region of the state. The smaller numeric and geographic 
educational regions may not have the infrastructure needed to accommodate young children 
diagnosed with OM or CL/P. Smaller communities may also lack quality early intervention 
opportunities and readily available therapeutic services in community agencies or school systems. 
Providing assessible medical care to treat children who receive an early diagnosis of OM may 
reduce long-term financial costs and increased educational outcomes.  
In addition, the current study did not find significant differences in the prevalence of 
chronic OM in preschool-age children with diagnoses of CL, CP, and CLP; PE tube treatment in 
children with CL/P; or the expected payer source for PE tube treatment with NM and REM 
children with CL/P. Results of the present study also indicated REM children were more likely to 
use public insurance. This is consistent with previous reports that Black children (without CL/P) 
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were more likely to have public insurance (Baerg et al., 2017). Although disparities did not exist 
in NM and REM children receiving PE tube treatment based on the expected payer source, it is 
crucial to be cognizant of potential socioeconomic factors. For one thing, families who utilize 
public insurance for their children’s medical bills may have other financial barriers. Equally 
important, these families may be less likely to request time off from work to seek early medical 
care if they are required to take unpaid leave. Families who use public insurance may avoid 
scheduling or following through with doctor recommendations to treat OM due to out-of-pocket 
costs. Not to mention, families from lower SES backgrounds may not have insurance with cost-
free options to seek second opinions when they disagree with the recommendation or lack of 
recommendation of their medical provider. Additionally, some families may not have reliable 
transportation or must access public transportation which could add costs and time for travel to 
and from the medical appointment. To address these and other challenges families may 
experience, social workers could provide resources for families to access to assist in overcoming 
potential barriers which may be preventing or delaying children from receiving hearing healthcare 
in a timely manner. Information on satellite healthcare providers who may be able to shorten the 
distance for families to travel to locations to receive services, may be an option to explore. 
Another possible solution to reduce the time for travel would be to offer telehealth to reduce 
travel while allowing patient and healthcare provider(s) opportunities to discuss symptoms, 
possible treatment options, and provide early hearing healthcare education. 
Limitations and Future Research 
The major strength of this study is that it utilized state-wide encounter data for inpatient 
and outpatient hospital visits in the state of NC. This study does however have several limitations. 
One limitation is the use of quantitative data which is not descriptive; therefore, it was difficult to 
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make decisions based solely on the restricted information that was collected. Another limitation is 
the use of secondary data prohibits direct observation that might have provided important insights 
into the interactions between caregivers and medical personnel. As this study was intentionally 
limited to patient data in the state of NC, it is possible some of these findings may not easily 
translate to other states or territories in or outside of the US.  
Future studies should consider including the demographic characteristics of care 
providers and medical personnel in addition to the children receiving medical services. This could 
include but not be limited to racial/ethnicity identification and knowledge of the geographic area. 
As the racial/ethnic diversity of NC and the US increases, medical personnel may not be familiar 
with cultural/home remedies or ease of access to traditional medicine which may delay families 
from seeking or complying with recommendations from providers of modern medicine. Future 
research also needs to examine the economic impact on families based on the method, distance 
and time traveled to the doctor’s office or Cleft Palate-Craniofacial Team site as well as other 
pertinent but less obvious reasons that delay or prevent the identification of chronic OM as well 
as resources for families of children diagnosed with CL/P. 
Medical personnel may not be familiar with the ability or difficulty for families to access 
and ultimately comply with recommendations based on geographical barriers which may exist in 
both urban and rural areas. Additional information could provide increased opportunities to 
investigate communications between the patient – caregiver – medical personnel triad; as well as, 
an understanding of how caregivers communicate concerns of their child’s frequency and severity 
of symptoms. One strategy that can be implemented to identify early hearing healthcare needs is 
the use of a community health assessment to determine the current needs and issues, as well as 
how and where to allocate resources. This or other collaborative efforts would allow stakeholders 
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including caregivers, audiologists, social workers, Cleft Palate-Craniofacial Team members, 
speech-language pathologists, educators and others to discuss successes and challenges including 
over- and under-identification of OM, access to medical care, identifying and communicating OM 
symptoms, as well as following recommendations. 
Summary and Conclusions 
The purpose of this study was an examination of the prevalence of middle ear disease, 
specifically chronic OM in NM and REM preschool-age children. In addition, the likelihood of 
NM and REM children with non-syndromic CL, CP, CLP being diagnosed with chronic OM and 
then receiving PE tube treatment was investigated. Finally, the use of PE tube treatment in NM 
and REM children with CL/P based on the expected payer source was explored. There were 
significant differences in the prevalence of chronic OM in NM and REM preschool-age children, 
with REM children under-identified in the diagnosis of chronic OM. Furthermore, REM children 
were less likely to be born with CP and CLP. This study did not identify significant differences in 
the prevalence of chronic OM in preschool-age children with diagnoses of CL, CP, and CLP; PE 
tube treatment in children with CL/P; or the expected payer source for PE tube treatment for NM 
and REM children with CL/P. It was noted that fewer REM children were identified with CL/P; 
therefore, more NM children were identified with CL/P, resulting in the opportunity for more 
frequent need for PE tube treatment. 
This study may be the first to address preschool-age children diagnosed with CL/P who 
received PE tube treatment by expected payer source in addition to racial/ethnic identification. 
Future studies should not only examine the reporting of OM symptoms by caregivers to medical 
personnel but also the access to quality early hearing healthcare interventions across racial/ethnic 
identification, geographic location, and payer source. The collaborative efforts of stakeholders to 
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increase effective communication between caregivers and medical personnel could increase the 
likelihood that all children receive quality early hearing healthcare. Consistent application of 
respective clinical practice guidelines is crucial to assist all children in achieving optimal school 
readiness skills and speech/language developmental milestones. Early identification of at-risk 
children, regardless of racial/ethnic identification or socioeconomic factors, is crucial to reduce 
and possibly eliminate existing hearing healthcare disparities. It is important to note that although 
some of the results were not statistically significant, the reported differences should be addressed 
to ensure no child is denied access to early hearing healthcare interventions.   
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APPENDIX A 
 
ICD-10-CM CODES DISEASES OF MIDDLE EAR AND MASTOID 
PROCESS CODES INFORMATION 
Variable       ICD-10-CM Code 
 
Acute serous otitis media  H65.00, H65.01, H65.02, H65.03, 
H65.04, H65.05, H65.06, H65.07 
 
Acute and subacute allergic otitis media (mucoid) (sanguinous) (serous)    
       H65.111, H65.112, H65.113, H65.114, 
H65.115, H65.116, H65.117, H65.119 
 
Other acute nonsuppurative otitis media   H65.191, H65.192, H65.193, H65.194, 
H65.195, H65.196, H65.197, H65.199 
 
Chronic serous otitis media H65.20, H65.21, H65.22, H65.23 
 
Chronic mucoid otitis media    H65.30, H65.31, H65.32, H65.33 
  
Chronic allergic otitis media    H65.411, H65.412, H65.413, H65.419 
  
Other chronic nonsuppurative otitis media  H65.491, H65.492, H65.493, H65.499 
  
Unspecified nonsuppurative otitis media   H65.90, H65.91, H65.92, H65.93 
 
Acute suppurative otitis media without spontaneous rupture of ear drum  
H66.001, H66.002, H66.003, H66.004, 
H66.005, H66.006, H66.007, H65.009 
 
Acute suppurative otitis media with spontaneous rupture of ear drum 
H66.011, H66.012, H66.013, H66.014, 
H66.015, H66.016, H66.017, H66.019 
 
Chronic tubotympanic suppurative otitis media  H66.10, H66.11, H66.12, H66.13 
  
Chronic atticoantral suppurative otitis media  H66.20, H66.21, H66.22, H66.23 
  
Other chronic suppurative otitis media   H66.3X1, H66.3X2, H66.3X3,  
H66.3X9 
 
Suppurative otitis media    H66.40, H66.41, H66.42, H66.43 
  
Otitis media      H66.90, H66.91, H66.92, H66.93 
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APPENDIX B 
 
CODING SYSTEM 
Name Description Values Missing 
Gender Indicator of sex 0 = Male 
1 = Female 
999 
PE_T_ 
Treatment  
CPT codes: PE Tube 
treatment: 69433 or 
69436  
0 = No PE Tube Treatment 
1 = Received PE Tube Treatment  
999 
DX_Cleft_ 
Lip 
Primary I10-D-CM 
diagnosis of CL 
0 = No Diagnosis of CL  
1 = Diagnosis of CL 
999 
DX_Cleft_ 
Palate 
Primary I10-D-CM 
diagnosis of CP 
0 = No Diagnosis of CP 
1 = Diagnosis of CP 
999 
DX_CLP Primary I10-D-CM 
diagnosis of CLP 
0 = No Diagnosis of CLP 
1 = Diagnosis of CLP 
999 
DX_CL_ 
and_or_P 
DX of Clefts of the 
Lip and/or Palate 
0 = No Diagnosis of CL/P 
1 = Diagnosis of CL/P 
 
DX_OM_ 
Acute 
Primary diagnosis of 
acute otitis media 
0 = No Diagnosis of Acute OM  
1 = Diagnosis of Acute OM 
999 
DX_OM_ 
Chronic 
Primary diagnosis of 
chronic otitis media 
0 = No Diagnosis of Chronic OM 
1 = Diagnosis of Chronic OM 
 
Expected_ 
Primary_ 
Payer 
Expected primary 
payer source 
 
0 = Private Insurance or Self-Pay 
1 = Public: Medicare, Medicaid, No charge, 
Other (gov programs) 
999 
Race_ 
Ethnicity 
Identification of 
patient’s race/ethnicity 
0 = Racial/Ethnic Non-Minority 
(White/Caucasian) 
1 = Racial/Ethnic Minority (Black/ African 
American; Hispanic; Asian/ Pacific 
Islander; Native American; Other 
999 
Zip Code Zip Codes by Region Northeast: Southeast: North Central; 
Sandhills; Piedmont Triad; Southwest; 
Northwest; Western; Outside of NC 
 
 
